Long term treatment with clozapine does not affect morning circulating levels of allopregnanolone and THDOC in patients with schizophrenia: A preliminary study

Journal of Clinical Psychopharmacology

Volumn 24, Issue 4, 2004, Pages 437-440

  Monteleone, Palmiero ^a   Fabrazzo, Michele ^a   Serra, Mariangela ^b   Tortorella, Alfonso ^a   Pisu, M Giuseppina ^b   Biggio, Giovanni ^b   Maj, Mario ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; ALLOTETRAHYDRODEOXYCORTICOSTERONE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; NEUROSTEROID; TETRAHYDRODEOXYCORTICOSTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; HUMAN; LONG TERM CARE; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANALYSIS OF VARIANCE; CIRCADIAN RHYTHM; CLOZAPINE; DESOXYCORTICOSTERONE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREGNANOLONE; PROSPECTIVE STUDIES; SCHIZOPHRENIA;

EID: 3242723179     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000130552.78501.1a     Document Type: Article

References (22)

1. Zinder O, Dar DE. Neuroactive steroids: their mechanism of action and their function in the stress response. Acta Physiol Scand. 1999;167:181-188.
2. Majewska MD, Harrison NL, Schwartz RD, et al. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 1996;232:1004-1007.
3. Wetzel CH, Hermann B, Behl C, et al. Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. Mol Endocrinol. 1998;12:1441-1451.
4. Rupprecht R, Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci. 1999;22:410-416.
5. Rupprecht R. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology. 2003;28:139-168.
6. Monteleone P, Luisi M, Colurcio B, et al. Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa. Psychosom Med. 2001;63:62-68.
7. Monteleone P, Luisi M, De G, et al. Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with non-obese healthy controls and non-binge eating obese subjects. Int J Eat Disord. 2003;39:932-940.
8. Barbaccia ML, Roscetti G, Trabucchi M, et al. The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br J Pharmacol. 1997;120:1582-1588.
9. Uzunova V, Sheline Y, Davis JM, et al. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA. 1998;95:3239-3244.
10. Barbaccia ML, Affricano D, Purdy RH, et al. Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat. Neuropsychopharmacology. 2001;25:489-497.
11. Marx CE, Duncan GE, Gilmore JH, et al. Olanzapine increases allopregnanolone in the rat cerebral cortex. Biol Psychiatry. 2000;47:1000-1004.
12. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45:789-796.
13. Lukoff D, Nuechterlein LH, Ventura J. Manual for Expanded Brief Psychiatric Rating Scale (BPRS). Schizophr Bull. 1986;12:592-602.
14. Volpicelli SA, Centorrino F, Puopolo PR, et al. Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography. Clin Chem. 1993;39:1656-1659.
15. Serra M, Madau P, Chessa MF, et al. 2-Phenyl-imidazo[1,2-a]pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action. Br J Pharmacol. 1999;127:177-187.
16. Purdy RH, Morrow AL, Blinn JR, et al. Synthesis, metabolism and pharmacological activity of 3α-hydroxy-steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes. J Med Chem. 1990;33:1572-1581.
17. Meltzer HY. An overview of the mechanism of action of clozapine. J Clin Psychiatry. 1994;55(suppl B):47-52.
18. Akbarian S, Kim JJ, Potkin SG, et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 1995;52:258-266.
19. Benes FM, Wickramasinghe R, Vincent SL, et al. Uncoupling of GABA(A) and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain. Brain Res. 1997;755:121-129.
20. Benes FM, Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology. 2001;25:1-27.
21. Nechmad A, Maayan R, Ramadan E, et al. Clozapine decreases rat brain dehydroepiandrosterone and dehydroepiandrosterone sulfate levels. Eur Neuropsychopharmacol. 2003;13:29-31.
22. Genazzani AR, Luisi M, Malavasi B, et al. Pulsatile secretory characteristics of allopregnanolone, a neuroactive steroid, during the menstrual cycle and in amenorrheic subjects. Eur J Endocrinol. 2002;146:347-356.